Identification of GRIN2D as a novel therapeutic target in pancreatic ductal adenocarcinoma
Abstract Background Pancreatic ductal adenocarcinoma (PDAC) is a devastating disease with a dismal prognosis, and despite significant advances in our understanding of its genetic drivers, like KRAS, TP53, CDKN2A, and SMAD4, effective therapies remain limited. Here, we identified a new therapeutic ta...
Saved in:
Main Authors: | Jiatong Wang (Author), Chi Hin Wong (Author), Yinxin Zhu (Author), Xiaoqiang Yao (Author), Kelvin K C Ng (Author), Chengzhi Zhou (Author), Ka Fai To (Author), Yangchao Chen (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2023-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Therapeutic Targeting of Autophagy in Pancreatic Ductal Adenocarcinoma
by: Alexander G. Raufi, et al.
Published: (2021) -
Hydrogel-Based Therapeutics for Pancreatic Ductal Adenocarcinoma Treatment
by: Jinlu Liu, et al.
Published: (2023) -
A rapid in vivo screen for pancreatic ductal adenocarcinoma therapeutics
by: Ozhan Ocal, et al.
Published: (2015) -
Surgical Treatment of Pancreatic Ductal Adenocarcinoma
Published: (2021) -
Nanoparticle-Based Therapeutic Strategies for Enhanced Pancreatic Ductal Adenocarcinoma Immunotherapy
by: Wanting Hou, et al.
Published: (2022)